1. Management of Mild Cases
- Mild cases can be managed at Covid Care Centre, First Referral Units (FRUs), Community Health Centre (CHC), sub-district and district hospitals or at home subject to conditions stipulated in the home isolation guidelines
- Detailed clinical history is taken including that of co-morbidities. Patient is followed up daily for temperature, vitals and Oxygen saturation (SpO2).
- Mild COVID-19 cases may be given symptomatic treatment such as antipyretic (Paracetamol) for fever and pain, adequate nutrition and appropriate rehydration.
- Tab Hydroxychloroquine (HCQ) may be considered for any of those having high risk features for severe disease (such as age> 60; Hypertension, diabetes, chronic lung/kidney/ liver disease, Cerebrovascular disease and obesity) under strict medical supervision.
2. Management of Moderate Cases
- Patients with suspected or confirmed moderate COVID-19 (pneumonia) is to be isolated to contain virus transmission.
- The defining clinical assessment parameters are Respiratory Rate of more than or equal to 24 and oxygen saturation (SpO2) of less than 94% on room air (range 90-94%).
- Such patients will be isolated in Dedicated Covid Health Centre (DCHC) or District hospital or Medical College hospitals.
- Clinical Management of Moderate cases include Oxygen Support and Anticoagulant therapy.
- Control of co-morbid condition
- Few patients with COVID-19 experience a secondary bacterial infection. Consider empiric antibiotic therapy as per local antibiogram and guidelines in older people, immune-compromised patients, and children < 5 years of age.
3. Management of Severe Cases
- Early supportive therapy and monitoring
- Management of hypoxemic respiratory failure and ARDS
- Management of septic shock